Literature DB >> 23332666

Clawing back: broadening the notion of metal chelators in medicine.

Katherine J Franz1.   

Abstract

The traditional notion of chelation therapy is the administration of a chemical agent to remove metals from the body. But formation of a metal-chelate can have biological ramifications that are much broader than metal elimination. Exploring these other possibilities could lead to pharmacological interventions that alter the concentration, distribution, or reactivity of metals in targeted ways for therapeutic benefit. This review highlights recent examples that showcase four general strategies of using principles of metal chelation in medicinal contexts beyond the traditional notion of chelation therapy. These strategies include altering metal biodistribution, inhibiting specific metalloenzymes associated with disease, enhancing the reactivity of a metal complex to promote cytotoxicity, and conversely, passivating the reactivity of metals by site-activated chelation to prevent cytotoxicity.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332666      PMCID: PMC3634900          DOI: 10.1016/j.cbpa.2012.12.021

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  35 in total

1.  Probing chelation motifs in HIV integrase inhibitors.

Authors:  Arpita Agrawal; Jamie DeSoto; Jessica L Fullagar; Kasthuraiah Maddali; Shahrzad Rostami; Douglas D Richman; Yves Pommier; Seth M Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-27       Impact factor: 11.205

2.  Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.

Authors:  David B Lovejoy; Patric J Jansson; Ulf T Brunk; Jacky Wong; Prem Ponka; Des R Richardson
Journal:  Cancer Res       Date:  2011-07-12       Impact factor: 12.701

3.  Chelation therapy trials halted.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

Review 4.  Wilson's disease.

Authors:  Aftab Ala; Ann P Walker; Keyoumars Ashkan; James S Dooley; Michael L Schilsky
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

Review 5.  Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease.

Authors:  Lauren E Scott; Chris Orvig
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

Review 6.  Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.

Authors:  Yu Yu; Jacky Wong; David B Lovejoy; Danuta S Kalinowski; Des R Richardson
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

7.  A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation.

Authors:  Louise K Charkoudian; David M Pham; Katherine J Franz
Journal:  J Am Chem Soc       Date:  2006-09-27       Impact factor: 15.419

8.  Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease.

Authors:  Carina Treiber; Andreas Simons; Markus Strauss; Mathias Hafner; Roberto Cappai; Thomas A Bayer; Gerd Multhaup
Journal:  J Biol Chem       Date:  2004-09-30       Impact factor: 5.157

9.  Mercury, vaccines, and autism: one controversy, three histories.

Authors:  Jeffrey P Baker
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

10.  Mitochondrial electron transport is the cellular target of the oncology drug elesclomol.

Authors:  Ronald K Blackman; Kahlin Cheung-Ong; Marinella Gebbia; David A Proia; Suqin He; Jane Kepros; Aurelie Jonneaux; Philippe Marchetti; Jerome Kluza; Patricia E Rao; Yumiko Wada; Guri Giaever; Corey Nislow
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

View more
  13 in total

1.  Searching for harmony in transition-metal signaling.

Authors:  Christopher J Chang
Journal:  Nat Chem Biol       Date:  2015-10       Impact factor: 15.040

Review 2.  Developing drugs targeting transition metal homeostasis.

Authors:  Claire M Weekley; Chuan He
Journal:  Curr Opin Chem Biol       Date:  2016-12-29       Impact factor: 8.822

3.  Stimulus-Responsive Prochelators for Manipulating Cellular Metals.

Authors:  Qin Wang; Katherine J Franz
Journal:  Acc Chem Res       Date:  2016-10-17       Impact factor: 22.384

4.  Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics.

Authors:  Howard S Roth; Rachel C Botham; Steven C Schmid; Timothy M Fan; Levent Dirikolu; Paul J Hergenrother
Journal:  J Med Chem       Date:  2015-04-20       Impact factor: 7.446

5.  Sirtuin inhibitor sirtinol is an intracellular iron chelator.

Authors:  R Gautam; E A Akam; A V Astashkin; J J Loughrey; E Tomat
Journal:  Chem Commun (Camb)       Date:  2015-03-25       Impact factor: 6.222

6.  A Cephalosporin-Tripodalamine Conjugate Inhibits Metallo-β-Lactamase with High Efficacy and Low Toxicity.

Authors:  Hongyan Tian; Yiwan Wang; Yang Dai; Anwen Mao; Wanqing Zhou; Xiaoli Cao; Hui Deng; Hao Lu; Lin Ding; Han Shen; Xiaojian Wang
Journal:  Antimicrob Agents Chemother       Date:  2022-09-12       Impact factor: 5.938

7.  Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.

Authors:  Hana Jansová; Miloslav Macháček; Qin Wang; Pavlína Hašková; Anna Jirkovská; Eliška Potůčková; Filip Kielar; Katherine J Franz; Tomáš Simůnek
Journal:  Free Radic Biol Med       Date:  2014-06-30       Impact factor: 7.376

Review 8.  New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.

Authors:  Sarah M Drawz; Krisztina M Papp-Wallace; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

9.  Bioinorganic Life and Neural Activity: Toward a Chemistry of Consciousness?

Authors:  Christopher J Chang
Journal:  Acc Chem Res       Date:  2017-03-21       Impact factor: 22.384

10.  Ultraviolet light triggers the conversion of Cu2+-bound Aβ42 aggregates into cytotoxic species in a copper chelation-independent manner.

Authors:  Xiongwei Dong; Zhe Zhang; Dan Zhao; Yaojing Liu; Yan Meng; Yong Zhang; Dan Zhang; Changlin Liu
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.